Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report Provides Insights Into Market Evolution And Growth Prospects

The minimally invasive glaucoma surgery (MIGS) devices market is on track for significant expansion, driven by advancements in surgical techniques and growing patient demand. As healthcare providers seek safer, more effective glaucoma treatments with quicker recovery times, this market is poised to become a key segment in ophthalmic care. Let us explore the market's projected value, major players, prominent trends, and detailed segment breakdowns shaping the future of MIGS devices.

Projected Market Valuation and Growth of the Minimally Invasive Glaucoma Surgery Devices Market
The MIGS devices market is expected to experience remarkable growth, reaching a valuation of $2.79 billion by 2030. This growth reflects a robust compound annual growth rate (CAGR) of 24.9%. Key factors behind this expansion include an increasing population of glaucoma patients, broader acceptance of minimally invasive surgical options, growing demand for outpatient ophthalmic procedures, heightened focus on improving patients' quality of life, and enhanced accessibility to specialized ophthalmology clinics. Important market trends anticipated during this period involve more widespread adoption of MIGS procedures, preference for MIGS in treating early to moderate stages of glaucoma, the combination of MIGS with cataract surgeries, expansion of ambulatory glaucoma surgical centers, and rising demand for safer, faster-recovery glaucoma treatments.

Download a free sample of the Minimally Invasive Glaucoma Surgery (MIGS) Devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Companies Dominating the Minimally Invasive Glaucoma Surgery Devices Market
Several influential companies are at the forefront of the MIGS devices market, including Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., and Beaver-Visitec International.

Significant Business Moves Supporting Market Growth
A notable development took place in July 2024 when Alcon Inc., a Switzerland-based medical device company, acquired BELKIN Vision Inc. for $81 million. This acquisition aims to boost the global uptake of Direct Selective Laser Trabeculoplasty (DSLT) as a frontline glaucoma treatment. BELKIN Vision Inc., headquartered in Israel, specializes in glaucoma laser therapy devices, and this strategic move is expected to accelerate innovation and adoption in this therapeutic area.

View the full Minimally Invasive Glaucoma Surgery (MIGS) Devices market report:
https://www.thebusinessresearchcompany.com/report/minimally-invasive-glaucoma-surgery-migs-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Innovations Shaping the Minimally Invasive Glaucoma Surgery Devices Market
Leading firms in the MIGS sector are actively developing advanced therapeutic solutions such as sustained-release drug-delivery implants to improve glaucoma management. These implants provide a continuous release of medication over time, enhancing patient adherence, reducing the need for frequent dosing, and improving overall treatment effectiveness. A prime example is the February 2024 partnership between Celanese Corporation, a US specialty materials firm, and Glaukos. Together, they launched the iDose® TR (Travoprost Intracameral Implant), which utilizes Celanese's VitalDose® Ethylene Vinyl Acetate (EVA) platform. This implant delivers travoprost directly into the eye for several months, replacing traditional eye drops. Integrated with Glaukos' MIGS portfolio, this minimally invasive device enhances intraocular pressure control, reduces daily medication burden, and supports better long-term outcomes.

Comprehensive Market Segmentation of the Minimally Invasive Glaucoma Surgery Devices Industry
The MIGS devices market is categorized into various segments for a detailed understanding of its structure:
1) Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm's Canal Devices
2) Surgical Approach: MIGS performed alongside cataract surgery, Stand-Alone MIGS procedures
3) Target Anatomical Pathway: Trabecular Meshwork, Schlemm's Canal, Suprachoroidal Space, Subconjunctival Space
4) Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS
5) End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals

Further Subdivisions Within Product Categories
In greater detail, trabecular micro-stents can be subdivided into single-lumen, multi-lumen, scaffold-based, and drug-eluting types. Subconjunctival micro-shunts are classified as gel-based, polymer-based, collagen-based, or fixed-lumen devices. Suprachoroidal stents are categorized into passive, flow-regulated, and biocompatible polymer variants. Canaloplasty and Schlemm's canal devices include microcatheter-based canaloplasty tools, viscodilation and expanders for Schlemm's canal, implant-free canaloplasty systems, and scaffolding devices for Schlemm's canal.

This comprehensive breakdown highlights the diversity and technological sophistication within the MIGS devices market, underscoring its potential for innovation and tailored patient care.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.